These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31420675)

  • 1. Tumoricidal stem cell therapy enables killing in novel hybrid models of heterogeneous glioblastoma.
    Satterlee AB; Dunn DE; Lo DC; Khagi S; Hingtgen S
    Neuro Oncol; 2019 Dec; 21(12):1552-1564. PubMed ID: 31420675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing Implantable Scaffolds to Enhance Neural Stem Cell Therapy for Post-Operative Glioblastoma.
    Sheets KT; Ewend MG; Mohiti-Asli M; Tuin SA; Loboa EG; Aboody KS; Hingtgen SD
    Mol Ther; 2020 Apr; 28(4):1056-1067. PubMed ID: 32109370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-homing cytotoxic human induced neural stem cells for cancer therapy.
    Bagó JR; Okolie O; Dumitru R; Ewend MG; Parker JS; Werff RV; Underhill TM; Schmid RS; Miller CR; Hingtgen SD
    Sci Transl Med; 2017 Feb; 9(375):. PubMed ID: 28148846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing Bioinspired Three-Dimensional Models of Brain Cancer to Evaluate Tumor-Homing Neural Stem Cell Therapy.
    Carey-Ewend AG; Hagler SB; Bomba HN; Goetz MJ; Bago JR; Hingtgen SD
    Tissue Eng Part A; 2021 Jul; 27(13-14):857-866. PubMed ID: 32907497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of systemic chemotherapy with local stem cell delivered S-TRAIL in resected brain tumors.
    Redjal N; Zhu Y; Shah K
    Stem Cells; 2015 Jan; 33(1):101-10. PubMed ID: 25186100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas.
    Kauer TM; Figueiredo JL; Hingtgen S; Shah K
    Nat Neurosci; 2011 Dec; 15(2):197-204. PubMed ID: 22197831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Peripherally Derived Neural-Like Stem Cells as Therapeutic Carriers for Treating Glioblastomas.
    Birbrair A; Sattiraju A; Zhu D; Zulato G; Batista I; Nguyen VT; Messi ML; Solingapuram Sai KK; Marini FC; Delbono O; Mintz A
    Stem Cells Transl Med; 2017 Feb; 6(2):471-481. PubMed ID: 28191774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and Profiling of Tumor-Homing Induced Neural Stem Cells from the Skin of Cancer Patients.
    Buckley A; Hagler SB; Lettry V; Bagó JR; Maingi SM; Khagi S; Ewend MG; Miller CR; Hingtgen SD
    Mol Ther; 2020 Jul; 28(7):1614-1627. PubMed ID: 32402245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle engineered TRAIL-overexpressing adipose-derived stem cells target and eradicate glioblastoma via intracranial delivery.
    Jiang X; Fitch S; Wang C; Wilson C; Li J; Grant GA; Yang F
    Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13857-13862. PubMed ID: 27849590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of composite scaffold degradation rate on neural stem cell persistence in the glioblastoma surgical resection cavity.
    Moore KM; Graham-Gurysh EG; Bomba HN; Murthy AB; Bachelder EM; Hingtgen SD; Ainslie KM
    Mater Sci Eng C Mater Biol Appl; 2020 Jun; 111():110846. PubMed ID: 32279815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting inherent intratumor heterogeneity in patient-derived glioblastoma culture models.
    Teng J; da Hora CC; Kantar RS; Nakano I; Wakimoto H; Batchelor TT; Chiocca EA; Badr CE; Tannous BA
    Neuro Oncol; 2017 Jun; 19(6):820-832. PubMed ID: 28062830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic stem cells expressing variants of EGFR-specific nanobodies have antitumor effects.
    van de Water JA; Bagci-Onder T; Agarwal AS; Wakimoto H; Roovers RC; Zhu Y; Kasmieh R; Bhere D; Van Bergen en Henegouwen PM; Shah K
    Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16642-7. PubMed ID: 23012408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Therapy Using Neural Stem/Progenitor Cells Derived from Human Induced Pluripotent Stem Cells: Visualization of Migration and Bystander Killing Effect.
    Tamura R; Miyoshi H; Morimoto Y; Oishi Y; Sampetrean O; Iwasawa C; Mine Y; Saya H; Yoshida K; Okano H; Toda M
    Hum Gene Ther; 2020 Mar; 31(5-6):352-366. PubMed ID: 32075424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Umbilical cord blood-derived mesenchymal stem cells inhibit, but adipose tissue-derived mesenchymal stem cells promote, glioblastoma multiforme proliferation.
    Akimoto K; Kimura K; Nagano M; Takano S; To'a Salazar G; Yamashita T; Ohneda O
    Stem Cells Dev; 2013 May; 22(9):1370-86. PubMed ID: 23231075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells.
    Stechishin OD; Luchman HA; Ruan Y; Blough MD; Nguyen SA; Kelly JJ; Cairncross JG; Weiss S
    Neuro Oncol; 2013 Feb; 15(2):198-207. PubMed ID: 23262510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors.
    Wakimoto H; Kesari S; Farrell CJ; Curry WT; Zaupa C; Aghi M; Kuroda T; Stemmer-Rachamimov A; Shah K; Liu TC; Jeyaretna DS; Debasitis J; Pruszak J; Martuza RL; Rabkin SD
    Cancer Res; 2009 Apr; 69(8):3472-81. PubMed ID: 19351838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrospun nanofibrous scaffolds increase the efficacy of stem cell-mediated therapy of surgically resected glioblastoma.
    Bagó JR; Pegna GJ; Okolie O; Mohiti-Asli M; Loboa EG; Hingtgen SD
    Biomaterials; 2016 Jun; 90():116-25. PubMed ID: 27016620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.
    Xia S; Lal B; Tung B; Wang S; Goodwin CR; Laterra J
    Neuro Oncol; 2016 Apr; 18(4):507-17. PubMed ID: 26320116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152.
    Yao Y; Ma J; Xue Y; Wang P; Li Z; Liu J; Chen L; Xi Z; Teng H; Wang Z; Li Z; Liu Y
    Cancer Lett; 2015 Apr; 359(1):75-86. PubMed ID: 25578780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.